Skip to Main Content

Issue Areas

  • Immigration Helping aspiring Americans and new immigrants succeed
  • Education Clearing pathways to a meaningful education
  • Environment Building solutions at the intersection of climate innovation and environmental justice.
  • XQ: The Super School Project Rethinking America's high schools
  • Chicago CRED Creating real economic destiny in Chicago
  • Equity & Justice Shaping new systems of opportunity for all
  • Media & Journalism Provoking thought and strengthening democracy
  • Health Accelerating cancer research and empowering patients

About Emerson

  • About Us A letter from Laurene Powell Jobs
  • Our Team Meet the members of the Collective
  • Our Fellowships Amplifying extraordinary voices
  • Internships We are looking for interns who are motivated to lead.
  • Careers Join the Collective

Share this page

  • facebook
  • twitter
  • linkedin

Solving One of the World's Biggest Health Problems with Technology

Health

Posted October 2018

Color Genomics Co-founder and CEO Othman Laraki talks to Healthcare Global.

What would it mean for the healthcare industry if the medical field focused on disease prevention and early detection? Huge savings in costs, better health outcomes for diagnosed patients, and—most importantly—longer, healthier lives.

Color is a population health service powered by genomics that empowers people to identify and take action to prevent serious, hereditary, health problems, like cancer, and high cholesterol. Patients order testing kits online, provide a saliva or blood sample, and receive results they can then share and discuss with their doctors.

"If you look at our healthcare spend, in the US especially but it's very similar across the world, most of it is on treating disease,” says Color Co-founder and CEO, Othman Laraki. “The basic model is that we wait for something to break and then we try to fix it. In the US only 3% of healthcare spend is on prevention. Just moving the cancer diagnosis up a stage... you double the survival rate and take out 50% of the cost.”

That’s a bigger impact than any other in the history of cancer therapy.

“It's achievable through prevention and early detection,” he says.

Read more via Healthcare Global.

Connected Stories

  • How to Make Sure Cancer Research Breakthroughs Make It To Patients

    A collaboration between Emerson Collective and Takeda offers a new model for helping scientists turn their discoveries into treatments.

    Health
  • Emerson Collective and Takeda Launch Oncology Innovation Accelerator Initiative: Advancing Oncology Therapeutics Through Creative Collaboration Focused on Research and Translational Science

    Innovative alliance of stakeholders aligns industry expertise and support offering academic investigators a new approach to accelerate patient-driven oncology research

    Health
  • The American Cancer Society and Emerson Collective Launch Grants to Encourage Collaborative Online Research

    Grants will support interdisciplinary teams who participate in the ACS’s online platform.

    Health

From Our Network

  • Demo Day '19: Max Krummel

    Professor Krummel is a champion of collaborative science; his ImmunoX Initiative promotes data sharing and joint research across fields, disciplines, demographics, and geographies.

    Health

Stay Informed

Join our mailing list and follow us on social.

Email address is not valid. Email addresses should follow the format user@domain.com and must originate from a valid domain.

You may unsubscribe at any time. By submitting information, you accept our Privacy Policy.

  • facebook
  • twitter
  • instagram
  • linkedin

Copyright © 2023 Emerson Collective

  • Terms and Conditions
  • Privacy Policy
  • Unsolicited Submission Policy
  • Fraudulent Requests